Protein therapy using MafA fused to a polyarginine transduction domain attenuates glucose levels of streptozotocin‑induced diabetic mice.
about
Protein therapy using MafA fused to a polyarginine transduction domain attenuates glucose levels of streptozotocin‑induced diabetic mice.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Protein therapy using MafA fus ...... zotocin‑induced diabetic mice.
@ast
Protein therapy using MafA fus ...... zotocin‑induced diabetic mice.
@en
type
label
Protein therapy using MafA fus ...... zotocin‑induced diabetic mice.
@ast
Protein therapy using MafA fus ...... zotocin‑induced diabetic mice.
@en
prefLabel
Protein therapy using MafA fus ...... zotocin‑induced diabetic mice.
@ast
Protein therapy using MafA fus ...... zotocin‑induced diabetic mice.
@en
P2093
P2860
P356
P1476
Protein therapy using MafA fus ...... ozotocin‑induced diabetic mice
@en
P2093
Huiyue Dong
Lianghu Huang
Lingjing Lin
Qinghua Wang
P2860
P304
P356
10.3892/MMR.2017.6536
P50
P577
2017-05-02T00:00:00Z